v3.25.2
Statements of Cash Flows - USD ($)
 8 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Cash flows from operating activities:    
Net income $ 171,389 $ 2,552,215
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned in assets held in trust (199,848) (3,617,001)
Change in operating assets and liabilities:    
Formation costs paid by Sponsor under Promissory Note – Related Party 3,618
Prepaid expenses (2,176)
Due to a related company 120,000
Accrued expenses 24,841 274,673
Net cash used in operating activities (672,289)
Cash flows from investing activities:    
Extension payments deposited in Trust Account (277,700)
Investment of cash in Trust Account (69,690,000)
Net cash used in investing activities (69,690,000) (277,700)
Cash flows from financing activities:    
Proceeds from issuance of ordinary shares to Sponsor 25,000
Proceeds from sale of units through public offering 69,000,000
Proceeds from sale of private placement units 3,320,000
Proceeds from promissory note – related party 206,533
Proceeds from extension promissory note – related party 277,700
Advance from related party 119,780
Payment of offering costs (2,070,665)
Repayment of promissory note – related party (210,151)
Net cash provided by financing activities 70,270,717 397,480
NET CHANGE IN CASH 580,717 (552,509)
CASH, BEGINNING OF PERIOD 580,717
CASH, END OF PERIOD 580,717 28,208
Non-cash investing and financing activities    
Deferred underwriting fee payable 690,000
Initial classification of shares subject to redemption 69,690,000
Remeasurement of ordinary stock subject to possible redemption 199,848 3,617,001
Extension funds attributable to common stock subject to redemption 277,700
Issuance of representative shares 7
Accretion of additional paid-in capital to accumulated deficit $ 105,878